1. Academic Validation
  2. Design, synthesis and biological evaluation of indane derived GPR40 agoPAMs

Design, synthesis and biological evaluation of indane derived GPR40 agoPAMs

  • Bioorg Med Chem Lett. 2019 Jul 15;29(14):1842-1848. doi: 10.1016/j.bmcl.2019.04.050.
Barbara Pio 1 Harry R Chobanian 2 Yan Guo 2 Hubert Josien 2 William K Hagmann 2 Michael Miller 2 Maria E Trujillo 3 Melissa Kirkland 3 Daniel Kosinski 3 Joel Mane 3 Michele Pachanski 3 Boonlert Cheewatrakoolpong 3 Eric Ashley 4 Robert Orr 4 Michael J Wright 5 Randal Bugianesi 5 Sarah Souza 5 Xiaoping Zhang 5 Jerry Di Salvo 5 Adam B Weinglass 5 Richard Tschirret-Guth 6 Koppara Samuel 6 Qing Chen 6 Jackie Shang 6 James Lamca 6 Juliann Ehrhart 7 Ravi Nargund 2 Andrew D Howard 3 Steven L Colletti 2
Affiliations

Affiliations

  • 1 Discovery Chemistry, Merck & Co., Inc, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: Barbara.pio@merck.com.
  • 2 Discovery Chemistry, Merck & Co., Inc, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • 3 In Vivo Pharmacology, Merck & Co., Inc, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • 4 Process Chemistry, Merck & Co., Inc, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • 5 In Vitro Pharmacology, Merck & Co., Inc, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • 6 Drug Metabolism and Pharmacokinetics, Merck & Co., Inc, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • 7 SALAR Discovery, Merck & Co., Inc, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
Abstract

GPR40 (FFAR1 or FFA1) is a G protein-coupled receptor, primarily expressed in pancreatic islet β-cells and intestinal enteroendocrine cells. When activated by fatty acids, GPR40 elicits increased Insulin secretion from islet β-cells only in the presence of elevated glucose levels. Towards this end, studies were undertaken towards discovering a novel GPR40 Agonist whose mode of action is via Positive Allosteric Modulation of the GPR40 receptor (AgoPAM). Efforts were made to identify a suitable GPR40 AgoPAM tool molecule to investigate mechanism of action and de-risk liver toxicity of GPR40 AgoPAMs due to reactive acyl-glucuronide (AG) metabolites.

Keywords

Diabetes; FFA1; GPCR; GPR40 AgoPAM; Indane.

Figures